HYDERABAD, India, August 10, 2018 /PRNewswire/ --
A premier industry event in South India by UBM India
UBM India, the organisers of CPhI / P-MEC India, the leading global pharma trade show and conference, today hosted the 5th edition of PharmaLytica 2018 in Hyderabad
(Logo: https://mma.prnewswire.com/media/675607/UBM_Logo.jpg )
(Logo: https://mma.prnewswire.com/media/726649/PharmaLytica_2018.jpg )
(Photo: https://mma.prnewswire.com/media/729194/Inauguration_Pharmalytica_5th_edition.jpg )
(Photo: https://mma.prnewswire.com/media/729195/Lamp_Lighting_Cermony_Pharmalytica.jpg )
PharmaLytica enables the pharmaceutical community procure the current industry trends, innovations and conduct business with Analytical, Laboratory, Machinery, Packaging and other allied Industries. The expo is well supported by associations, including Pharmexcil, Confederation of Indian Pharmaceutical Industry (CiPi) and Indian Drug Manufacturers' Association (IDMA).
In the current edition, PharmaLytica is witnessing participation from over 150 exhibitors from across the country including notable industry players such as Kirloskar, Standard Group of Companies, Borosil Glass Works, Bry-Air Asia, Rotomark Innovations, Control Print, Gandhi Automation, Leistung Engineering, Mack Pharmatech, Domino Printech, Autocal Solutions, FLIR Systems, Helios Concrew, Kirloskar Pneumatics, S.K. Pharma Machinery, NPM Machinery, Goel Scientific, GMM Pfaudler, ELGI Equipments, First Source Lab, Apex Chromatography, Valfit Engineers, Integrated Cleanroom Technology, Dumra Machines, Sigma Scientific Glass, among many others.
Looking ahead, from 2019, the expo is set to grow and further expand its reach into the Western region with its strong pharma market by hosting PharmaLytica for the first time in Mumbai. While targeting the South-West market with sectors such as Lab & Analytical, Pharma Machinery & Packaging, PharmaLytica will also launch API and Excipients zone to continue it's pre-eminence in this region. This will enhance the exhibition profile as a one stop shop for all end-to-end Pharma solutions under one roof.
Speaking at the launch of the 5th edition of PharmaLytica in Hyderabad, Mr. Yogesh Mudras, Managing Director, UBM India said, "The Indian Pharma economy has been lauded for its rapid growth in recent decades. Within this market, Analytical, Bio-technology, Lab equipments, Pharma Machinery and Pharma Packaging sectors in India are set for amplification owing to quality, research, regulatory and environmental compliances. Therefore, the need of the hour for the Indian pharmaceutical players is to achieve maximum efficiency from the potential of today's landscape with better product and service offerings. At PharmaLytica, every participant gets an opportunity to pick up on the latest industry trends and innovations as well as network with the Pharma business community offering each other a value proposition. The conference that is being held on the sidelines of the expo, seeks to deepen understanding of the changing landscape in the sector to enable responses to the ongoing market trends."
"Given our growing and unparalleled offering in the Pharma domain, we are pleased to announce PharmaLytica' s move to Mumbai in 2019, aiming to add immense value to the strong Western market in addition to the Southern one," he further added.
Speaking at the occasion, Mr. Uday Bhaskar Reddy, Director General, Pharmaceuticals Export Promotion Council (PHARMEXCIL) said, "In FY 2017-18, Indian Pharma exports grew to USD 17.26 billion. One of the key development to notice is, despite 8% negative growth witnessed in the US market, we still grew positive by 2.92%. There are potential markets to explore like China, South Africa and CIS markets and even if negative growth continues in the US market, the Indian Pharma companies should be confident and focus on growth and explore opportunities in the potential markets."
A series of insightful sessions and panel discussions convened by industry experts are being organized to discuss the trending subjects in Quality Assurance, Technology, Quality Culture and Regulatory & Compliance Standards in the Pharmaceutical Sector. The conference focuses on the growth phase, challenges and how the industry can again truly distinguish itself in the global pharma industry in the years to come.
Day One (10th August) - 'Quality Culture - Revolutionizing Dynamics of Quality Assurance'
Session 1 - 'A Smart Pharma Manufacturing for Operational Excellence; Latest in Pharmaceutical, Analytical Lab' - Dr. P V Appaji, Former DG, Pharmexcil
Speakers - Dr. Devraj Rambhau, Director - Technical, Pulse Pharma, Dr. Vishwas Sovani, Founder Director, Pharma wisdom and Mr. M Radhakrishnan, Head-HR , Apex Lab, Chennai
Session 2 - How Technology Provide the Edge for Quality Assurance - Mr. Rajesh Rathi, International Society for Automation; Control infotech, USA
Speakers - Mr. Subbarao V Kattamuri, Head , Aztec India and Mr. Vijay Kirpalani, President, Flow Chemistry Society, India
Session 3 (i) - Effectively managing HR to control cost, but assuring Quality - Mr. Satish Rajkondawar, Technology Consultant, Pharma
Speakers - Dr. Nagarjuna Akula, Vice President Quality , Shanta Biotech and Ganesh Balakrishnan, Partner, Deloitte Hanskins & Sells, LLP
Session 3 (ii) - Quality Culture Parameters - Concept & Practice - Dr. R B Smarta, Managing Director, Interlink Marketing Consultancy
Speakers - Nilesh Dhamorikar, MD, QBD Research & Development Lab and Mr. Prajwal Bhat, Achila Laboratories
Day Two (11th August) - 'Regulatory & Pricing - A Challenge for Pharma Sector'
Speakers - Mr. Yognandan Pandya, Associate Director, Strategic Marketing & External Affairs, USP India, Dr. Eswara Reddy - DCGI and Dr. Shubhro K Ghosh, Group Leader, Patient Access Service, Novartis Healthcare
Session 1 - Is Regulatory Compliance much more than GMP? - Ganadhish Kamat, Executive VO & Head, Global Quality organisation, Dr Reddy's Laboratory
Speakers - Shri Nilesh Gandhi, Assistant Commissioner, FDA, Govt of Maharashtra and Dr. Linga Rao, President - Technical Affairs, Natco
Panel Discussion -
Regulatory, Pricing & Patients - Equilibrium - will be moderated by Utkarsh Palnitkar, Partner, KPMG / Dr R B Smarta, Managing Director, Interlink Marketing Consultancy
Dignitaries - Dr. Preeti Meena IAS, Director, Drugs Control Administration, Telangana, Shri Nilesh Gandhi, Assistant Commissioner, FDA, Govt of Maharashtra, Sri M.B.R. Prasad, Director, Drugs Control Administration, Andhra Pradesh, Ms Binita Kundu, AR Strategist, Global Regulatory Affairs, Pfizer Healthcare India, and Mr. Hasin Solmaz, GM , LightHouse Worldwide Solutions, Turkey.
To know more about the event and register for a free entry to the event, visit http://www.ubmindia.in/pharmalytica
About UBM Asia
UBM Asia recently became part of Informa PLC, a leading B2B information services group and the largest B2B Events organiser in the world. Please visit http://www.ubm.com/asia for more information about our presence in Asia.
PharmaLytica is organised by UBM, which in June 2018 combined with Informa PLC to become a leading B2B information services group and the largest B2B Events organiser in the world.
Please visit http://www.ubm.com/india for more information about our presence in India.
Media Contact: Mili Lalwani firstname.lastname@example.org +91-9833279461 UBM India
Roshni Mitra email@example.com UBM India
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All